These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 24832911)

  • 1. Anabolic-androgenic steroid use among Brazilian bodybuilders.
    Nogueira FR; Brito Ade F; Oliveira CV; Vieira TI; Gouveia RL
    Subst Use Misuse; 2014 Jul; 49(9):1138-45. PubMed ID: 24832911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Illicit use and abuse of anabolic-androgenic steroids among Brazilian bodybuilders.
    Santos AM; da Rocha MS; da Silva MF
    Subst Use Misuse; 2011; 46(6):742-8. PubMed ID: 21114402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of anabolic steroid use and associated factors among body-builders in Hamadan, West province of Iran.
    Razavi Z; Moeini B; Shafiei Y; Bazmamoun H
    J Res Health Sci; 2014; 14(2):163-6. PubMed ID: 24728754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of the use of anabolic-androgenic steroids in Brazil: a systematic review.
    Abrahin OS; Sousa EC; Santos AM
    Subst Use Misuse; 2014 Jul; 49(9):1156-62. PubMed ID: 24766401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anabolic androgenic steroids--use and correlates among gym users--an assessment study using questionnaires and observations at gyms in the Stockholm region.
    Leifman H; Rehnman C; Sjöblom E; Holgersson S
    Int J Environ Res Public Health; 2011 Jul; 8(7):2656-74. PubMed ID: 21845151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training.
    Ip EJ; Barnett MJ; Tenerowicz MJ; Perry PJ
    Pharmacotherapy; 2011 Aug; 31(8):757-66. PubMed ID: 21923602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of concomitant use of alcohol, tobacco, cocaine, and anabolic steroids on lipid profiles of Brazilian recreational bodybuilders.
    Schwingel PA; Zoppi CC; Cotrim HP
    Subst Use Misuse; 2014 Jul; 49(9):1115-25. PubMed ID: 24766402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ruptured Tendons in Anabolic-Androgenic Steroid Users: A Cross-Sectional Cohort Study.
    Kanayama G; DeLuca J; Meehan WP; Hudson JI; Isaacs S; Baggish A; Weiner R; Micheli L; Pope HG
    Am J Sports Med; 2015 Nov; 43(11):2638-44. PubMed ID: 26362436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of the use of anabolic agents among strength training apprentices in Porto Alegre, RS].
    Silva PR; Machado LC; Figueiredo VC; Cioffi AP; Prestes MC; Czepielewski MA
    Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):104-10. PubMed ID: 17435863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgenic anabolic steroid use in matric pupils. A survey of prevalence of use in the western Cape.
    Schwellnus MP; Lambert MI; Todd MP; Juritz JM
    S Afr Med J; 1992 Sep; 82(3):154-8. PubMed ID: 1519133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study.
    Pope HG; Kanayama G; Hudson JI
    Biol Psychiatry; 2012 Feb; 71(3):254-61. PubMed ID: 21839424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychological and physical impact of anabolic-androgenic steroid dependence.
    Ip EJ; Lu DH; Barnett MJ; Tenerowicz MJ; Vo JC; Perry PJ
    Pharmacotherapy; 2012 Oct; 32(10):910-9. PubMed ID: 23033230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and correlates of anabolic-androgenic steroid use in a nationally representative sample of 17-year-old Norwegian adolescents.
    Sagoe D; Andreassen CS; Molde H; Torsheim T; Pallesen S
    Subst Use Misuse; 2015 Jan; 50(2):139-47. PubMed ID: 25265519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Athletes' perceptions toward substance use in Baghdad city.
    Habeeb MB; Kasim WJ; Khamees LA; Hawi MM; Khashoom QN
    Am J Mens Health; 2012 Nov; 6(6):462-71. PubMed ID: 22713800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting future anabolic-androgenic steroid use intentions with current substance use: findings from an internet-based survey.
    Dunn M; Mazanov J; Sitharthan G
    Clin J Sport Med; 2009 May; 19(3):222-7. PubMed ID: 19423975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ["No" for stacked young bodybuilders, "yes" for manthers: the biomedical discourse on anabolic steroids and health].
    Moraes DR; Castiel LD; Ribeiro AP
    Cad Saude Publica; 2015 Jun; 31(6):1131-40. PubMed ID: 26200362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Qualitative description of the prevalence and use of anabolic androgenic steroids by United States powerlifters.
    Curry LA; Wagman DF
    Percept Mot Skills; 1999 Feb; 88(1):224-33. PubMed ID: 10214647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence of anabolic steroid use among competitive bodybuilders.
    Tricker R; O'Neill MR; Cook D
    J Drug Educ; 1989; 19(4):313-25. PubMed ID: 2621538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors of anabolic-androgenic steroids (AAS) abuse among adolescents and young adults in Poland.
    Rachoń D; Pokrywka L; Suchecka-Rachoń K
    Soz Praventivmed; 2006; 51(6):392-8. PubMed ID: 17658145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body composition, cardiovascular risk factors and liver function in long-term androgenic-anabolic steroids using bodybuilders three months after drug withdrawal.
    Hartgens F; Kuipers H; Wijnen JA; Keizer HA
    Int J Sports Med; 1996 Aug; 17(6):429-33. PubMed ID: 8884417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.